Newly Diagnosed Atrial Fibrillation in Acute Myocardial InfarctionYuki Obayashi, Yasuaki Takeji, Tomohisa Tada et al.|Journal of the American Heart Association|2021Cited by 66
Rationale and study design of the GOREISAN for heart failure (GOREISAN-HF) trial: A randomized clinical trialHidenori Yaku, Takeshi Kimura, Takao Kato et al.|American Heart Journal|2023Cited by 21
Effects of Acute Coronary Syndrome and Stable Coronary Artery Disease on Bleeding and Ischemic Risk After Percutaneous Coronary InterventionMasahiro Natsuaki, Takeshi Morimoto, Hiroki Shiomi et al.|Circulation Journal|2021Cited by 18
Percutaneous Coronary Intervention Versus Coronary Artery Bypass Graftinge Among Patients with Unprotected Left Main Coronary Artery Disease in the New-Generation Drug-Eluting Stents Era (From the CREDO-Kyoto PCI/CABG Registry Cohort-3)Ko Yamamoto, Takeshi Kimura, Hiroki Shiomi et al.|The American Journal of Cardiology|2021Cited by 17